HLS Therapeutics Inc
F:74D
HLS Therapeutics Inc
F:74D
Price:
2.74
EUR
1.48%
Market Closed
Market Cap:
€87.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
HLS Therapeutics Inc
F:74D
|
CA |
|
Lenzing AG
F:LEN
|
AT |
|
Airtel Africa PLC
F:9AA0
|
UK |
|
DIC Asset AG
XETRA:DIC
|
DE |
|
M
|
Mycronic AB (publ)
F:MLT0
|
SE |
|
Airtel Africa PLC
LSE:AAF
|
UK |
Wall St Price Targets
74D Price Targets Summary
HLS Therapeutics Inc
HLS Therapeutics Inc
Wall Street analysts forecast 74D stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 74D is 5.96 EUR with a low forecast of 3.24 EUR and a high forecast of 9.07 EUR.
Lowest Forecast
Price Target
3.24
EUR
18% Upside
Average Forecast
Price Target
5.96
EUR
117% Upside
Highest Forecast
Price Target
9.07
EUR
231% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 74D's stock price target?
Price Target
5.96
EUR
5.96
EUR
According to Wall Street analysts, the average 1-year price target for 74D is 5.96 EUR with a low forecast of 3.24 EUR and a high forecast of 9.07 EUR.
What is the Revenue forecast for HLS Therapeutics Inc?
Projected CAGR
10%
10%
Over the last 14 years, the compound annual growth rate for Revenue has been -3%. The projected CAGR for the next 6 years is 10%.
